47 Participants Needed

Communication Intervention for Cancer Care

(PRECursOr Trial)

Recruiting at 1 trial location
AS
Overseen ByAshley Sheets
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Indiana University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this study is to help test an idea designed to foster more supportive talk between providers (doctors or nurse practitioners), patients, and caregivers during an outpatient oncology appointment. A caregiver is the person the patient identifies is primarily involved in their healthcare. This study is collecting your reaction to this idea in order to understand needed changes before we introduce the idea to a larger group of patients.

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications. It seems focused on communication during appointments, so it's unlikely that medication changes are required.

What data supports the idea that Communication Intervention for Cancer Care is an effective treatment?

The available research shows that effective communication in cancer care, such as the Communication Intervention for Cancer Care, improves patient understanding, satisfaction, and psychological adjustment. For example, one study highlights that meaningful communication helps patients better understand their disease and increases their satisfaction with care. Another study found that communication training for healthcare providers led to significant improvements in their confidence when talking to patients. These improvements suggest that the treatment is effective in enhancing the overall experience and outcomes for cancer patients.12345

What safety data exists for the Communication Intervention for Cancer Care?

The provided research does not directly address safety data for the Communication Intervention for Cancer Care or its variants. The studies focus on the efficacy and implementation of communication skills training in oncology, highlighting improvements in communication behaviors, patient comprehension, and clinician self-efficacy. However, they do not provide specific safety data or evaluations of potential risks associated with these interventions.14678

Is the treatment in the trial 'Communication Intervention for Cancer Care' a promising treatment?

Yes, the treatment is promising because effective communication in cancer care can improve patient understanding, satisfaction, and treatment outcomes. Training programs like COMSKIL show that communication skills can be taught and lead to better decision-making and emotional support for patients.1791011

Eligibility Criteria

This trial is for adult women with advanced, incurable gynecologic cancers who are at a critical point in their illness and have not responded well to initial treatments. They must speak English and not be receiving palliative care or hospice. Caregivers primarily involved in the patient's care can also participate if they meet similar language criteria.

Inclusion Criteria

My current treatment isn't working, my illness is getting worse, or I was hospitalized due to symptoms in the last month.
I am a woman with advanced gynecologic cancer that has not improved with treatment.
Read/speak English
See 4 more

Exclusion Criteria

I do not have speech or hearing difficulties that would prevent me from participating.
I or my caregiver have cognitive difficulties.

Treatment Details

Interventions

  • Intervention group triads
Trial OverviewThe study tests an intervention aimed at improving communication between healthcare providers, patients with gynecologic cancer, and their caregivers during outpatient appointments. It seeks feedback on this approach before expanding it to more people.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention group triadsExperimental Treatment1 Intervention
Group II: Control group triadsActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Indiana University

Lead Sponsor

Trials
1,063
Recruited
1,182,000+

American Cancer Society, Inc.

Collaborator

Trials
237
Recruited
110,000+

Findings from Research

Effective communication, both verbal and nonverbal, is crucial in breast oncology as it enhances patients' understanding of their disease and treatment options.
Improving communication in doctor-patient interactions leads to better patient compliance and satisfaction, which can positively influence psychological adjustment to breast cancer over time.
[Communicating the results in breast oncology: nonverbal and verbal exchange].Barreau, B., Tastet, S.[2019]
Effective communication between patients and oncologists is crucial and can be improved through various strategies, including enhancing the patient-physician relationship and addressing patient emotions.
Despite the wealth of descriptive data on communication practices, there is a lack of intervention studies that directly connect improved communication to better patient outcomes in oncology.
Patient-physician communication in oncology: what does the evidence show?Back, A.[2006]
In a study involving English-speaking adults with ovarian cancer, patient-centred communication (PCC) significantly improved health-related quality of life (HRQoL), with a total effect size of 9.47, indicating that effective communication is crucial for patient well-being.
Self-efficacy was found to mediate about 63.4% of the relationship between PCC and HRQoL, suggesting that enhancing patients' confidence in managing their health could be a key focus for interventions aimed at improving their quality of life.
Health-related quality of life, patient-centred communication and self-efficacy in ovarian cancer: a mediation analysis.Pozzar, RA., Xiong, N., Mazzola, E., et al.[2022]

References

[Communicating the results in breast oncology: nonverbal and verbal exchange]. [2019]
Patient-physician communication in oncology: what does the evidence show? [2006]
Health-related quality of life, patient-centred communication and self-efficacy in ovarian cancer: a mediation analysis. [2022]
Developing and implementing an advanced communication training program in oncology at a comprehensive cancer center. [2022]
Clinician-patient communication: a systematic review. [2022]
Efficacy of communication skills training for giving bad news and discussing transitions to palliative care. [2022]
["He does not know it yet"-Triadic communication and its pitfalls exemplified by an oncological ward round consultation]. [2022]
Filling in the gaps: reporting of concurrent supportive care therapies in breast cancer chemotherapy trials. [2021]
Family communication during the cancer experience. [2009]
Physician-patient-companion communication and decision-making: a systematic review of triadic medical consultations. [2022]
COMSKIL Communication Training in Oncology-Adaptation to German Cancer Care Settings. [2019]